Bioeclosion

BioEclosion on La Ventana Cadena Ser with Carles Francino

Isabel Pividori — Mon, 16 Mar 2026 20:32:08 +0000

We are delighted to share that BioEclosion was featured on Cadena SER in Los Revolucionarios, as part of La Ventana with Carles Francino. In this interview, Jofre Ferrer-Dalmau, CEO and co-founder of BioEclosion, explains how our technology is helping transform rapid diagnostics by bringing testing closer to people, without the need to go to a ...

The post BioEclosion on La Ventana Cadena Ser with Carles Francino appeared first on Bioeclosion.

Bioeclosion highlights next-generation biosensor innovation at 4YFN-MWC 2026 with stand presence and investor pitch

Isabel Pividori — Sat, 14 Mar 2026 07:42:03 +0000

Showcasing its technology at the UAB stand and selected to pitch at the BKA Pitch Corner, Bioeclosion presented its portable diagnostic device to investors, partners, and innovation stakeholders at Europe’s leading startup event. Barcelona, March 2026 — Bioeclosion participated in 4YFN-MWC 2026, the startup event held within the Mobile World Congress programme in Barcelona, where the company ...

The post Bioeclosion highlights next-generation biosensor innovation at 4YFN-MWC 2026 with stand presence and investor pitch appeared first on Bioeclosion.

BioEclosion at Mobile World Congress 2026. Next-generation biosensors at 4YFN

Isabel Pividori — Mon, 02 Mar 2026 12:25:11 +0000

BioEclosion will be at Mobile World Congress 2026 (2–5 March, Barcelona) within the UAB stand (8.1C43), exhibiting next-generation biosensor technology for advanced diagnostic devices. BioEclosion will also pitch at the BKA Pitch Corner on 3 March, connecting with investors and partners across the deep-tech ecosystem. BioEclosion will be at Mobile World Congress (MWC) 2026 in ...

The post BioEclosion at Mobile World Congress 2026. Next-generation biosensors at 4YFN appeared first on Bioeclosion.

BioEclosion and UAB featured by the European Commission’s Innovation Radar for a market-ready rapid diagnostic biosensor

Isabel Pividori — Thu, 19 Feb 2026 11:49:56 +0000

A rapid diagnostic technology developed by BioEclosion and the Universitat Autònoma de Barcelona (UAB) has been assessed by the European Commission’s Innovation Radar and classified as “Market Ready”, with “Market Creation Potential: Noteworthy”. The European Commission, through its Innovation Radar initiative, has evaluated and selected an innovation developed within the EU-funded EChiLiBRiST project. The innovation ...

The post BioEclosion and UAB featured by the European Commission’s Innovation Radar for a market-ready rapid diagnostic biosensor appeared first on Bioeclosion.

Towards accessible Alzheimer’s diagnostics: brain-derived exosomes measured with BioEclosion’s portable electrochemical device

Isabel Pividori — Mon, 02 Feb 2026 12:09:55 +0000

A recent study demonstrates a point-of-care electrochemical biosensing workflow to quantify an Alzheimer’s-relevant marker on neuron-origin exosomes isolated from plasma. The assay is implemented in a disposable, magneto-actuated cartridge and the electrochemical signal is acquired using BioEclosion’s portable device. Early diagnosis of Alzheimer’s disease remains one of the major challenges in healthcare, largely because many ...

The post Towards accessible Alzheimer’s diagnostics: brain-derived exosomes measured with BioEclosion’s portable electrochemical device appeared first on Bioeclosion.

Featuring BioEclosion cartridge in biosensing research in breast cancer detection based on exosomes

Isabel Pividori — Tue, 01 Jul 2025 11:13:29 +0000

Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In an exciting development for the field of medical diagnostics, our latest product, the specialized cartridge for biosensing applications, has been featured in a pioneering study published in Biosensors and Bioelectronics. This study, titled “Peptide-based biosensing approaches for targeting breast cancer-derived exosomes”, marks a significant milestone in ...

The post Featuring BioEclosion cartridge in biosensing research in breast cancer detection based on exosomes appeared first on Bioeclosion.

Bioeclosion joins ‘Industrial Startups Day’ by S2 Xpeed and ‘Forùm Arquímedes’ by PRUAB

Isabel Pividori — Tue, 01 Jul 2025 10:28:49 +0000

At Bioeclosion, the last month of 2024 has been truly inspiring! As a spin-off from UAB, Bioeclosion participated in the annual ‘Fòrum Arquímedes’ event, which brought together all spin-off companies from the university at the ‘Casa de la Convalescència’ in Barcelona, Spain, on December 10th. It was a networking event aimed at building community and ...

The post Bioeclosion joins ‘Industrial Startups Day’ by S2 Xpeed and ‘Forùm Arquímedes’ by PRUAB appeared first on Bioeclosion.

BioEclosion at 4YFN 2025 Mobile World Congress. Advancing Innovation in Diagnostics

Isabel Pividori — Tue, 01 Jul 2025 10:26:20 +0000

We are thrilled to announce that BioEclosion will be participating in 4 Years From Now (4YFN), the premier event for startups, held under the umbrella of the Mobile World Congress (MWC) Barcelona from March 3-6, 2025. As a spin-off of the Universitat Autònoma de Barcelona (UAB), BioEclosion is proud to be among the pioneering companies featured at the UAB stand (8.1C42). At ...

The post BioEclosion at 4YFN 2025 Mobile World Congress. Advancing Innovation in Diagnostics appeared first on Bioeclosion.

Bioeclosion SL participates in BioSpain 2023 and Fira de la Innovació de la UAB

systems_gfpjfose — Mon, 02 Dec 2019 16:19:00 +0000

Dr. Jofre Ferrer-Dalmau, CEO of BioEclosion, has recently participated in the last edition of BioSpain Congress, organized in Barcelona, 26-28th of September 2023.

The post Bioeclosion SL participates in BioSpain 2023 and Fira de la Innovació de la UAB appeared first on Bioeclosion.

Thank you for visiting us at 4YFN 2025 @MWC

Isabel Pividori — Wed, 27 Nov 2019 16:17:00 +0000

What a week at 4 Years From Now (4YFN) 2025 Congress held within the Mobile World Congress (MWC) in Barcelona BioEclosion proudly presented its prototype of next-generation biosensor-based diagnostic device at the UAB stand (8.1C42) to 4YFN-MWC attendees. After 4 busy days presenting our patented technology, we are even more commited and motivated to fulfill our mission: enhance early disease detection and ...

The post Thank you for visiting us at 4YFN 2025 @MWC appeared first on Bioeclosion.